Ken Draper

1.5k total citations
23 papers, 1.3k citations indexed

About

Ken Draper is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ken Draper has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ken Draper's work include Herpesvirus Infections and Treatments (13 papers), Mosquito-borne diseases and control (7 papers) and Viral Infections and Vectors (6 papers). Ken Draper is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), Mosquito-borne diseases and control (7 papers) and Viral Infections and Vectors (6 papers). Ken Draper collaborates with scholars based in United States, Germany and United Kingdom. Ken Draper's co-authors include E K Wagner, Robert H. Costa, Thomas P. Monath, Farshad Guirakhoo, R J Frink, Inessa S. Levenbook, Juan Arroyo, John Catalan, К. В. Пугачев and Richard Nichols and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Virology.

In The Last Decade

Ken Draper

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Draper United States 17 606 560 548 197 170 23 1.3k
Samantha Brandler France 13 505 0.8× 579 1.0× 305 0.6× 149 0.8× 129 0.8× 13 911
Chantal Combredet France 18 288 0.5× 615 1.1× 561 1.0× 282 1.4× 288 1.7× 34 1.2k
Oskar‐Rüger Kaaden Germany 15 189 0.3× 301 0.5× 320 0.6× 135 0.7× 125 0.7× 24 716
Sébastien Plumet France 14 527 0.9× 600 1.1× 263 0.5× 83 0.4× 183 1.1× 19 1.0k
Gopal Sapparapu United States 20 655 1.1× 900 1.6× 413 0.8× 81 0.4× 194 1.1× 30 1.4k
Marina N. Fleeton Ireland 17 349 0.6× 542 1.0× 276 0.5× 214 1.1× 400 2.4× 20 1.1k
Milind M. Gore India 17 668 1.1× 707 1.3× 461 0.8× 99 0.5× 170 1.0× 44 1.3k
Ronald C. Weir Australia 15 718 1.2× 618 1.1× 204 0.4× 76 0.4× 84 0.5× 24 1.1k
Marie‐Pascale Frenkiel France 23 1.5k 2.5× 1.4k 2.5× 440 0.8× 183 0.9× 342 2.0× 32 2.1k
Inessa S. Levenbook United States 17 528 0.9× 770 1.4× 174 0.3× 107 0.5× 57 0.3× 45 1.2k

Countries citing papers authored by Ken Draper

Since Specialization
Citations

This map shows the geographic impact of Ken Draper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Draper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Draper more than expected).

Fields of papers citing papers by Ken Draper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Draper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Draper. The network helps show where Ken Draper may publish in the future.

Co-authorship network of co-authors of Ken Draper

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Draper. A scholar is included among the top collaborators of Ken Draper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Draper. Ken Draper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodge, Thomas, Ken Draper, Trevor Brasel, et al.. (2016). Antiviral effect of ranpirnase against Ebola virus. Antiviral Research. 132. 210–218. 16 indexed citations
2.
Capaldi, Daniel C., Doug A. Brooks, Ken Draper, et al.. (2012). Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients. Drug Information Journal. 46(5). 611–626. 23 indexed citations
3.
Wehner, Nancy, George M. Shopp, J. Arly Nelson, et al.. (2009). Immunotoxicity profile of natalizumab. Journal of Immunotoxicology. 6(2). 115–129. 16 indexed citations
4.
Alarcon, Jason B., Ken Draper, R. Early, et al.. (2005). Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates. Human Vaccines. 1(3). 106–111. 84 indexed citations
5.
Monath, Thomas P., Gwendolyn A. Myers, W. Tad Archambault, et al.. (2005). Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys. Biologicals. 33(3). 131–144. 43 indexed citations
6.
Guirakhoo, Farshad, Gene Myers, Barbara W. Johnson, et al.. (2004). A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys. Journal of Virology. 78(18). 9998–10008. 37 indexed citations
7.
Guirakhoo, Farshad, К. В. Пугачев, Gene Myers, et al.. (2004). Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates. Journal of Virology. 78(9). 4761–4775. 205 indexed citations
8.
9.
10.
Monath, Thomas P., Inessa S. Levenbook, Kenneth F. Soike, et al.. (2000). Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys. Journal of Virology. 74(4). 1742–1751. 117 indexed citations
11.
Draper, Ken & Vickie Brown‐Driver. (1991). Reduction of herpes simplex virus infection using phosphorothioate oligonucleotides complementary to viral mRNA. Antiviral Research. 15. 106–106. 4 indexed citations
12.
Brandt, Curtis R., et al.. (1991). An antisense oligonucleotide to the HSV-1 UL-13 gene is effective against herpetic keratitis. Antiviral Research. 15. 120–120. 1 indexed citations
13.
Ostrander, Michael, et al.. (1988). MTX5: a cell line expressing biologically active HSV-1 Vmw65 protein. Nucleic Acids Research. 16(10). 4735–4735. 4 indexed citations
14.
Draper, Ken, G B Devi-Rao, Robert H. Costa, et al.. (1986). Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. Journal of Virology. 57(3). 1023–1036. 73 indexed citations
15.
Costa, Robert H., Ken Draper, Thomas J. Kelly, & E K Wagner. (1985). An unusual spliced herpes simplex virus type 1 transcript with sequence homology to Epstein-Barr virus DNA. Journal of Virology. 54(2). 317–328. 64 indexed citations
16.
Costa, Robert H., Ken Draper, G B Devi-Rao, Richard Thompson, & E K Wagner. (1985). Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5). Journal of Virology. 56(1). 19–30. 39 indexed citations
17.
Draper, Ken, et al.. (1984). Herpes simplex virus types 1 and 2 homology in the region between 0.58 and 0.68 map units. Journal of Virology. 52(2). 615–623. 11 indexed citations
18.
Costa, Robert H., Ken Draper, Lawrence Banks, et al.. (1983). High-Resolution Characterization ofHerpesSimplex Virus Type1Transcripts Encoding Alkaline Exonuclease anda 50,000-Dalton Protein Tentatively Identified asaCapsid Protein. 1 indexed citations
19.
Costa, Robert H., Ken Draper, Lawrence Banks, et al.. (1983). High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein. Journal of Virology. 48(3). 591–603. 72 indexed citations
20.
Draper, Ken, R J Frink, & E K Wagner. (1982). Detailed characterization of an apparently unspliced beta herpes simplex virus type 1 gene mapping in the interior of another. Journal of Virology. 43(3). 1123–1128. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Brandler Breakdown of academic impact, for papers by Chantal Combredet Breakdown of academic impact, for papers by Oskar‐Rüger Kaaden Breakdown of academic impact, for papers by Sébastien Plumet Breakdown of academic impact, for papers by Gopal Sapparapu Breakdown of academic impact, for papers by Marina N. Fleeton Breakdown of academic impact, for papers by Milind M. Gore Breakdown of academic impact, for papers by Ronald C. Weir Breakdown of academic impact, for papers by Marie‐Pascale Frenkiel Breakdown of academic impact, for papers by Inessa S. Levenbook
Rankless by CCL
2026